Fitzpatrick Margaret M Insider Trades

Insider Trading History

Track insider trading activity for Fitzpatrick Margaret M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director
Holding Value $11.7k 17,600 shares
Last Trade
Sep 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.5k 17,600 shares
$3.61
$0.66
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $44.8k 8,610 shares
Last Trade
May 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.2k 8,610 shares
$1.18
$5.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $99.4k 19,111 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.7k 19,111 shares
$1.19
$5.20
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director
Holding Value $9.37k 14,100 shares
Last Trade
Sep 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.8k 14,100 shares
$3.25
$0.66
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $335k 64,503 shares
Last Trade
Jun 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 64,503 shares
$2.00
$5.20
Vistagen Therapeutics
Vistagen Therapeutics VTGN
Director
Holding Value $8.31k 12,500 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.6k 12,500 shares
$4.85
$0.66
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $123k 23,742 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 23,742 shares
$5.91
$5.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $53.9k 10,362 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 10,362 shares
$17.28
$5.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $59.6k 11,463 shares
Last Trade
May 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 11,463 shares
$18.24
$5.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up